Skip to main content
Fig. 5 | Genome Medicine

Fig. 5

From: Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways

Fig. 5

Prognostic evaluation of CSK methylation and expression in HGSOC patients. a, b Kaplan–Meier plots showing PFS (a) and OS (b) for the two patient groups defined based on CSK methylation using a Cox proportional hazard model in HGSOC cohorts (n = 89 and n = 91, respectively). c, d Kaplan–Meier plots showing PFS (c) and OS (d) for the two patient clusters based on CSK expression using a Cox proportional hazard model in HGSOC cohorts (n = 633 and n = 656, respectively)

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us